MONSTER BEVERAGE CORP (MNST)

US61174X1090 - Common Stock

53.14  -0.32 (-0.6%)

After market: 53.08 -0.06 (-0.11%)

Fundamental Rating

6

MNST gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 32 industry peers in the Beverages industry. MNST gets an excellent profitability rating and is at the same time showing great financial health properties. While showing a medium growth rate, MNST is valued expensive at the moment. This makes MNST very considerable for quality investing!



7

1. Profitability

1.1 Basic Checks

MNST had positive earnings in the past year.
In the past year MNST had a positive cash flow from operations.
Each year in the past 5 years MNST has been profitable.
Each year in the past 5 years MNST had a positive operating cash flow.

1.2 Ratios

The Return On Assets of MNST (16.84%) is better than 96.88% of its industry peers.
Looking at the Return On Equity, with a value of 19.82%, MNST is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
MNST has a better Return On Invested Capital (17.72%) than 90.63% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MNST is significantly above the industry average of 12.50%.
Industry RankSector Rank
ROA 16.84%
ROE 19.82%
ROIC 17.72%
ROA(3y)16.29%
ROA(5y)18.62%
ROE(3y)19.25%
ROE(5y)22.33%
ROIC(3y)18.43%
ROIC(5y)20.59%

1.3 Margins

MNST has a better Profit Margin (22.84%) than 96.88% of its industry peers.
MNST's Profit Margin has declined in the last couple of years.
MNST's Operating Margin of 27.36% is amongst the best of the industry. MNST outperforms 84.38% of its industry peers.
MNST's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 53.14%, MNST is doing good in the industry, outperforming 65.63% of the companies in the same industry.
In the last couple of years the Gross Margin of MNST has declined.
Industry RankSector Rank
OM 27.36%
PM (TTM) 22.84%
GM 53.14%
OM growth 3Y-7.9%
OM growth 5Y-4.11%
PM growth 3Y-9.34%
PM growth 5Y-2.62%
GM growth 3Y-2.71%
GM growth 5Y-2%

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MNST is creating value.
The number of shares outstanding for MNST has been reduced compared to 1 year ago.
MNST has less shares outstanding than it did 5 years ago.
MNST has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 25.71 indicates that MNST is not in any danger for bankruptcy at the moment.
MNST's Altman-Z score of 25.71 is amongst the best of the industry. MNST outperforms 96.88% of its industry peers.
MNST has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
MNST has a better Debt to FCF ratio (0.00) than 87.50% of its industry peers.
MNST has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
MNST's Debt to Equity ratio of 0.00 is amongst the best of the industry. MNST outperforms 90.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 25.71
ROIC/WACC1.91
WACC9.28%

2.3 Liquidity

A Current Ratio of 4.81 indicates that MNST has no problem at all paying its short term obligations.
MNST has a better Current ratio (4.81) than 96.88% of its industry peers.
A Quick Ratio of 3.97 indicates that MNST has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.97, MNST belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.81
Quick Ratio 3.97

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.91% over the past year.
Measured over the past years, MNST shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.82% on average per year.
The Revenue has grown by 13.13% in the past year. This is quite good.
Measured over the past years, MNST shows a quite strong growth in Revenue. The Revenue has been growing by 13.40% on average per year.
EPS 1Y (TTM)39.91%
EPS 3Y-13.62%
EPS 5Y-2.82%
EPS growth Q2Q33.33%
Revenue 1Y (TTM)13.13%
Revenue growth 3Y15.8%
Revenue growth 5Y13.4%
Revenue growth Q2Q14.36%

3.2 Future

The Earnings Per Share is expected to grow by 14.19% on average over the next years. This is quite good.
MNST is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.08% yearly.
EPS Next Y19.19%
EPS Next 2Y16.31%
EPS Next 3Y14.92%
EPS Next 5Y14.19%
Revenue Next Year11.22%
Revenue Next 2Y10.62%
Revenue Next 3Y10.55%
Revenue Next 5Y9.08%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 34.06, the valuation of MNST can be described as expensive.
MNST's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of MNST to the average of the S&P500 Index (24.76), we can say MNST is valued slightly more expensively.
The Price/Forward Earnings ratio is 28.58, which means the current valuation is very expensive for MNST.
MNST's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. MNST is more expensive than 62.50% of the companies in the same industry.
MNST is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.26, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 34.06
Fwd PE 28.58

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MNST indicates a slightly more expensive valuation: MNST is more expensive than 65.63% of the companies listed in the same industry.
MNST's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 36.96
EV/EBITDA 25.43

4.3 Compensation for Growth

MNST's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of MNST may justify a higher PE ratio.
MNST's earnings are expected to grow with 14.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.78
PEG (5Y)N/A
EPS Next 2Y16.31%
EPS Next 3Y14.92%

0

5. Dividend

5.1 Amount

No dividends for MNST!.
Industry RankSector Rank
Dividend Yield N/A

MONSTER BEVERAGE CORP

NASDAQ:MNST (4/19/2024, 4:20:01 PM)

After market: 53.08 -0.06 (-0.11%)

53.14

-0.32 (-0.6%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap55.30B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 34.06
Fwd PE 28.58
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.84%
ROE 19.82%
ROCE
ROIC
ROICexc
ROICexgc
OM 27.36%
PM (TTM) 22.84%
GM 53.14%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.81
Quick Ratio 3.97
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)39.91%
EPS 3Y-13.62%
EPS 5Y
EPS growth Q2Q
EPS Next Y19.19%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)13.13%
Revenue growth 3Y15.8%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y